Authors:
Monali Tayade, Sampada Kulkarni
Download free PDF
Medical Equipment Maintenance Market Size & Share 2026-2035
Report ID: GMI15264
|
Published Date: November 2026
|
Report Format: PDF/Excel/Dashboard/Platform
Explore Our Licensing Options:
Medical Equipment Maintenance Market
Get a free sample of this report
What are you hoping to find?
Your PDF is on its way. Tell us little about your research goal, and we'll help you find the most relevant market insights.
Medical Equipment Maintenance Market Size
The global Medical Equipment Maintenance Market was valued at USD 59.7 billion in 2025, is projected to reach USD 70.1 billion by 2027, and is expected to expand at ~8.0% CAGR (2025–2035) to USD 127.9 billion by 2035.
Medical Equipment Maintenance Market Key Takeaways
Market Leader: Siemens Healthineers led with over 8.2% market share in 2025.
Leading Players: Top 5 players in this market include Siemens Healthineers, GE HealthCare, Philips Healthcare, Medtronic, Baxter International, which collectively held a market share of 23.7% in 2025.
The Medical Equipment Maintenance Market is being reshaped by a larger installed base of software-intensive imaging, monitoring, surgical, laboratory, and therapeutic systems. Higher utilization raises the operational cost of downtime, while documented service, calibration, and performance-management requirements are moving spending from episodic repair toward planned lifecycle coverage across OEM, independent service organization (ISO), and in-house channels.
GMI Analyst View
Based on input from industry leaders, the global Medical Equipment Maintenance Market was valued at USD 55.0 billion in 2024. We view this progression as evidence that expanding device fleets, greater maintenance intensity, and more formal service contracting are creating a durable revenue base despite labor and access constraints.
Medical Equipment Maintenance Market Trends, Growth Drivers & GMI Forecast Outlook
Chronic-care demand, quality-system formalization, and connected-device service models are making maintenance expenditure more recurring and compliance-sensitive. The forecast depends on providers converting utilization pressure into structured coverage while managing technician scarcity, proprietary service access, and affordability barriers among smaller facilities.
Key Drivers
Evidence anchors use cited external data; demand implications and forecast conditions represent GMI analysis.
Chronic disease care creates a persistent utilization floor for imaging, monitoring, and therapeutic assets. Facilities cannot readily defer calibration, inspection, or planned replacement work when high-acuity systems are scheduled continuously; the commercial consequence is greater preference for uptime-oriented coverage rather than repair-only purchasing.
Quality-system alignment changes maintenance from an operational preference into a controlled process. Formal service records, calibration traceability, and approved supplier arrangements favor providers able to integrate field service with documentation workflows. This particularly supports contract adoption where facilities have historically relied on informal internal repair practices.
Predictive maintenance is changing the unit of service from a repair event to asset performance management. Condition data and failure forecasting enable providers to sequence interventions around clinical schedules, reduce emergency callouts, and differentiate on availability outcomes. The shift is commercially important for multi-vendor ISOs as well as OEMs, although its value depends on device connectivity and access to relevant diagnostic data.
Key Restraints
Evidence anchors use cited external data; demand implications and forecast conditions represent GMI analysis.
The biomedical equipment technician shortage is a capacity constraint rather than simply a labor-cost issue. It can lengthen response times, limit in-house coverage of advanced systems, and increase dependence on external providers. The result is a mixed market effect: outsourcing demand improves, but available service capacity and affordability can limit total expenditure growth.
OEM control over proprietary software, diagnostic tools, parts, and device-specific training remains a meaningful competitive barrier. These restrictions are most consequential in complex imaging, robotic surgery, and radiotherapy categories, where independent providers must absorb higher qualification and compliance costs before competing for premium contracts.
Cost-sensitive providers often preserve liquidity by selecting partial coverage or reactive repair arrangements. That decision can defer formal contract adoption even where uptime risk is high, leaving an opening for modular coverage models but constraining penetration of comprehensive lifecycle agreements.
GMI Analyst View
We believe the market's strongest advantage is the increasing non-discretionary nature of equipment uptime and compliance spending. Its principal uncertainty is not demand creation, but whether service capacity, proprietary access, and provider budgets allow that demand to convert into broader full-coverage contract penetration.
Medical Equipment Maintenance Market Segment Analysis
By Service Type
Preventive maintenance generated USD 27.1 billion in 2025 and is projected to reach USD 61.0 billion by 2035.
Preventive coverage benefits from its role in reducing unplanned downtime while satisfying scheduled inspection, calibration, and documentation needs. The model is especially embedded in high-capital systems where an interruption affects clinical throughput, patient scheduling, and regulatory readiness.
Corrective maintenance represented 37.5% of expenditure in 2025 and is projected to generate USD 44.0 billion by 2035.
Corrective work remains essential for aging fleets and facilities with partial service coverage, but its relative role is being reshaped by condition monitoring and scheduled interventions. Demand is likely to remain concentrated where procurement remains repair-led and preventive infrastructure is less mature.
Operational and performance maintenance generated USD 10.2 billion in 2025 and is anticipated to expand at 8.5% CAGR (2025–2035).
This category gains relevance as medical equipment incorporates more software, connectivity, and performance-sensitive functions. Providers that can combine upgrade management, optimization, and certification into recurring service offerings are positioned to extend their role beyond traditional mechanical repair.
By Service Provider
OEM services generated USD 24.8 billion in 2025 and are projected to reach USD 50.9 billion by 2035.
OEMs retain a structural advantage where servicing requires proprietary firmware, calibrated tools, original parts, and manufacturer-specific technical knowledge. Their ability to bundle maintenance with equipment acquisition, upgrades, and long-duration lifecycle arrangements supports retention among large health systems.
ISOs accounted for 33.2% of expenditure in 2025 and are forecast to grow at 8.5% CAGR (2025–2035).
ISOs compete most effectively where hospitals operate heterogeneous fleets and seek multi-vendor coverage with tighter cost control. Their expansion will depend on access to parts and diagnostics, certified technical talent, and their ability to demonstrate compliant service outcomes across multiple equipment brands.
In-house maintenance teams generated USD 15.1 billion in 2025 and are expected to account for 25.2% of expenditure by 2035.
Internal teams remain important for first-response activity, lower-acuity assets, and local knowledge of facility workflows. However, advanced imaging, robotic, and life-support equipment increasingly require specialist capabilities that make a hybrid internal-and-outsourced model more practical for many providers.
By Equipment Type
Diagnostic imaging equipment generated USD 16.7 billion in 2025 and is projected to reach USD 36.1 billion by 2035.
The category carries intensive service requirements involving mechanical components, image quality, software, safety controls, and specialized calibration. High acquisition values and the clinical cost of scanner downtime make comprehensive lifecycle coverage a central procurement consideration.
Patient monitoring and life-support equipment accounted for 14.1% of expenditure in 2025 and is projected to generate USD 18.1 billion by 2035.
Maintenance intensity is driven by patient-safety exposure and continuous utilization in acute-care environments. Providers must maintain reliable inspection, software, and performance controls across distributed critical-care fleets, favoring documented service processes.
Surgical instruments and robotic surgery systems generated USD 7.9 billion in 2025 and are expected to grow at 9.0% CAGR (2025–2035).
Robotic and precision surgical platforms require specialized calibration, software support, sterility-related controls, and narrowly trained engineers. As installations widen beyond early-adopter hospitals, service capacity and manufacturer-qualified expertise become more material determinants of availability.
Laboratory and diagnostic equipment represented 10.9% of expenditure in 2025 and is projected to generate USD 13.4 billion by 2035.
Instrument qualification, calibration, and workflow continuity are central to laboratory maintenance demand. The segment favors providers that can maintain traceability across analytical platforms while minimizing disruption to time-sensitive diagnostic operations.
Therapeutic electromedical equipment generated USD 5.3 billion in 2025 and is expected to account for 8.5% of expenditure by 2035.
Energy-based therapeutic platforms combine electrical safety obligations with performance requirements that are closely tied to clinical outcomes. Their servicing therefore requires technical expertise that extends beyond routine device repair.
Endoscopic equipment represented 8.0% of expenditure in 2025 and is projected to generate USD 10.3 billion by 2035.
Frequent reprocessing, leak testing, optical inspection, and turnaround demands produce a dense maintenance cycle. Service quality is closely linked to procedure availability, making timely repair and verification particularly valuable in hospital and ambulatory settings.
Radiotherapy and medical laser equipment generated USD 4.2 billion in 2025 and is projected to grow at 8.0% CAGR (2025–2035).
The need for precision performance validation and safety-sensitive servicing supports OEM-led coverage in this category. Providers require specialized expertise to address the operational and compliance implications of radiation and laser technologies.
Dental equipment represented 4.9% of expenditure in 2025 and is projected to generate USD 5.7 billion by 2035.
The category is fragmented across independent practices, clinic networks, and varied equipment types. Scale purchasing by dental chains may broaden structured service adoption, while smaller practices are more likely to prioritize flexible or event-based arrangements.
Ophthalmology equipment generated USD 1.8 billion in 2025 and is expected to account for 2.7% of expenditure by 2035.
Precision optical and surgical equipment requires recurring performance assurance, particularly in cataract and retinal-care settings. Demand is supported by the clinical importance of optical accuracy and the need to protect procedure throughput.
By End Use
Hospitals generated USD 28.4 billion in 2025 and are expected to account for 45.2% of expenditure by 2035.
Hospitals operate the broadest and most capital-intensive fleets, creating demand for integrated maintenance across imaging, surgery, monitoring, laboratory, and therapeutic systems. Their scale also supports sophisticated procurement models that combine device lifecycle planning with compliance and uptime management.
Clinics, including specialty and dental clinics, represented 15.1% of expenditure in 2025 and are projected to generate USD 19.4 billion by 2035.
As more specialized procedures move into outpatient settings, clinics are operating increasingly complex equipment portfolios. Their service decisions balance rising clinical requirements against narrower operating budgets than large acute-care systems.
Ambulatory surgery centers generated USD 6.0 billion in 2025 and are anticipated to expand at 9.5% CAGR (2025–2035).
ASCs are becoming more maintenance-intensive as they adopt advanced anesthesia, imaging, and surgical technologies. Distributed sites and tightly scheduled procedures make rapid response, predictable downtime management, and certified multi-platform support especially valuable.
Diagnostic imaging centers accounted for 10.1% of expenditure in 2025 and are projected to generate USD 14.2 billion by 2035.
High-throughput imaging operations depend on device availability and predictable scan capacity. Their maintenance strategies emphasize preventive coverage, rapid corrective response, and service windows that limit disruption to patient schedules.
Dialysis centers generated USD 4.2 billion in 2025 and are expected to grow at 8.0% CAGR (2025–2035).
Frequent treatment cycles make machine reliability, water-system performance, and calibration discipline operational priorities. The segment is well suited to recurring maintenance arrangements because service lapses can directly disrupt scheduled patient care.
Clinical and research laboratories represented 6.0% of expenditure in 2025 and are projected to generate USD 8.1 billion by 2035.
Laboratories require qualified service for analytical instruments, biosafety infrastructure, and specialized platforms. Maintenance purchasing is shaped by validation requirements and the high cost of workflow interruptions in diagnostic and research environments.
GMI Analyst View
We see service intensity becoming less tied to facility size and more tied to technology mix. Procedure migration is extending hospital-grade maintenance requirements into outpatient settings, while highly specialized systems are raising the value of providers that can deploy certified expertise across distributed care networks.
Medical Equipment Maintenance Market Regional Analysis
North America Medical Equipment Maintenance Market Analysis
The North America Medical Equipment Maintenance Market generated USD 19.0 billion in 2025 and is expected to account for 29.3% of expenditure by 2035.
The region's mature hospital infrastructure, established OEM presence, and formal quality-management environment support multi-year service arrangements. Health-system consolidation further favors enterprise contracts that can cover diverse assets, standardize maintenance practices, and combine lifecycle planning with vendor accountability.
U.S.
The U.S. generated USD 16.6 billion in 2025 and is projected to reach USD 32.6 billion by 2035.
Large integrated delivery networks provide an important commercial base for comprehensive, multi-vendor service models. Aging imaging fleets, capital refresh decisions, and growing attention to documentation reinforce demand for maintenance programs that can manage both equipment availability and compliance obligations.
Canada
Canada generated USD 2.4 billion in 2025 and is forecast to grow at 7.4% CAGR (2025–2035).
Centralized procurement and publicly funded provincial systems favor lifecycle planning across large equipment fleets. Service providers that can align with standardized tenders and support geographically dispersed facilities have a meaningful operational advantage.
Europe Medical Equipment Maintenance Market Analysis
Europe represented 24.8% of expenditure in 2025 and is projected to generate USD 29.1 billion by 2035.
The region's regulatory and procurement environment supports formal documentation of device performance throughout the lifecycle. OEM subsidiaries and regional ISOs compete within established hospital networks, where service value increasingly rests on traceability, uptime, and integration with capital-equipment planning.
Germany
Germany generated USD 3.5 billion in 2025 and is expected to account for 5.4% of expenditure by 2035.
A strong domestic device-manufacturing base and large university hospital network support demand for specialized maintenance across imaging, surgical, and laboratory assets. OEM service infrastructure remains particularly influential in complex equipment categories.
UK
The UK represented 4.2% of expenditure in 2025 and is projected to generate USD 4.9 billion by 2035.
Large institutional fleets and managed equipment service procurement models encourage long-term arrangements that bundle acquisition, maintenance, and technology refresh. This structure rewards providers able to sustain performance across complex public and private care environments.
France
France generated USD 2.1 billion in 2025 and is forecast to grow at 7.0% CAGR (2025–2035).
Centralized purchasing and regional health-administration structures shape maintenance contracting for major hospital equipment. The market favors reliable tender execution and consistent support across acute-care and university-hospital networks.
Italy
Italy represented 3.3% of expenditure in 2025 and is projected to generate USD 3.9 billion by 2035.
Regional variation in health-system administration produces a fragmented procurement environment. Modernization of public hospital infrastructure should broaden the maintained equipment base, although service adoption will continue to vary by region and provider resources.
Spain
Spain generated USD 1.4 billion in 2025 and is expected to grow at 7.2% CAGR (2025–2035).
Public hospital concession models have created opportunities for private maintenance-management participation. These arrangements can accelerate adoption of structured OEM and ISO coverage where accountability for asset performance is embedded in broader operating contracts.
Netherlands
The Netherlands represented 1.7% of expenditure in 2025 and is projected to generate USD 2.0 billion by 2035.
A concentrated hospital and academic medical-center landscape supports demand for sophisticated multi-vendor programs. Providers benefit from being able to manage high-value interventional and imaging assets across integrated clinical networks.
Asia Pacific Medical Equipment Maintenance Market Analysis
The Asia Pacific Medical Equipment Maintenance Market generated USD 17.0 billion in 2025 and is expected to grow at 9.2% CAGR (2025–2035).
Expansion of hospital capacity and advanced-device installations is enlarging the addressable service base, while regulatory formalization is improving the conditions for structured contracts. The key commercial question is how quickly local service infrastructure, qualified personnel, and contract penetration mature alongside the installed base.
China
China generated USD 6.1 billion in 2025 and is expected to grow at 9.0% CAGR (2025–2035).
Hospital modernization and a larger installed base of imaging and monitoring equipment support service demand. Greater emphasis on post-market documentation is encouraging more formal maintenance practices within public hospital networks.
Japan
Japan represented 5.7% of expenditure in 2025 and is projected to generate USD 7.0 billion by 2035.
A technologically dense healthcare system creates durable demand for maintenance, particularly in imaging. High clinical utilization and rigorous post-market oversight support recurring expenditure on service quality, performance assurance, and equipment availability.
India
India generated USD 2.4 billion in 2025 and is expected to grow at 11.0% CAGR (2025–2035).
Private hospital-chain expansion, diagnostic-network investment, and public infrastructure development are increasing the device base that requires professional servicing. Market expansion will favor providers that can balance formal quality requirements with the cost sensitivity of a diverse facility base.
South Korea
South Korea represented 2.2% of expenditure in 2025 and is projected to generate USD 2.9 billion by 2035.
High technology adoption and a sophisticated hospital sector support demand for premium service capabilities. Maintenance requirements are particularly robust in imaging, robotic surgery, and patient-monitoring applications where performance assurance is tightly linked to clinical operations.
Australia
Australia generated USD 1.0 billion in 2025 and is expected to grow at 7.7% CAGR (2025–2035).
New hospital capacity and long-term public procurement frameworks are extending the maintained device fleet. Providers with strong tender-management and lifecycle-support capabilities are well positioned to serve state-managed healthcare systems.
Latin America Medical Equipment Maintenance Market Analysis
Latin America represented 8.0% of expenditure in 2025 and is projected to generate USD 10.6 billion by 2035.
Infrastructure investment and private healthcare development are expanding demand, but budget constraints continue to limit comprehensive contract penetration. The market retains substantial reliance on reactive and partial-coverage service models, creating a differentiated opportunity for flexible, lower-cost maintenance offerings.
Brazil
Brazil generated USD 2.2 billion in 2025 and is forecast to grow at 8.3% CAGR (2025–2035).
Private hospital and diagnostic-center investment is supporting gradual adoption of more structured maintenance programs. Regulatory quality expectations also encourage formalization, particularly among providers operating advanced diagnostic equipment.
Mexico
Mexico represented 2.2% of expenditure in 2025 and is projected to generate USD 2.9 billion by 2035.
Growing private-sector investment and large public provider networks create opportunities for multi-year service tenders. Uptake will depend on whether providers can combine documentation discipline with commercially viable coverage structures.
Argentina
Argentina generated USD 0.5 billion in 2025 and is expected to grow at 7.2% CAGR (2025–2035).
Economic volatility constrains capital-equipment investment and broad contract adoption. However, urban private hospital groups and diagnostic-center chains continue to require dependable preventive and corrective support for essential clinical assets.
Middle East & Africa (MEA) Medical Equipment Maintenance Market Analysis
The Middle East & Africa (MEA) Medical Equipment Maintenance Market generated USD 4.1 billion in 2025 and is expected to grow at 8.9% CAGR (2025–2035).
Healthcare infrastructure build-out is expanding the regional device base, especially in Gulf markets, while post-market compliance frameworks are becoming more formal. Growth will remain uneven because premium contract adoption is strongest in well-funded systems, while affordability constrains coverage elsewhere.
Saudi Arabia
Saudi Arabia generated USD 1.2 billion in 2025 and is anticipated to expand at 9.5% CAGR (2025–2035).
Hospital construction, privatization initiatives, and diagnostic expansion are creating demand for professional service infrastructure. Regional OEM hubs and growing institutional procurement support adoption of higher-value maintenance arrangements.
UAE
The UAE represented 1.5% of expenditure in 2025 and is projected to generate USD 2.2 billion by 2035.
A concentrated private healthcare and diagnostic-center market supports demand for premium equipment coverage. Formal maintenance documentation and high expectations for technology availability favor structured OEM and certified ISO support.
South Africa
South Africa generated USD 0.6 billion in 2025 and is expected to grow at 7.2% CAGR (2025–2035).
The public-private healthcare divide produces different maintenance models across the market. Private providers are more likely to maintain formal service contracts, while evolving public-sector standards may progressively increase structured maintenance demand.
GMI Analyst View
We expect geographic growth to hinge on the quality of local service ecosystems rather than equipment installations alone. Faster-growing regions can create durable maintenance revenue only when technician training, parts access, certification, and provider procurement evolve alongside the installed base.
Medical Equipment Maintenance Market Share & Competitive Landscape
The Medical Equipment Maintenance Market share structure remains fragmented: the top five participants collectively held approximately ~23.7% of expenditure in 2025. Fragmentation reflects the diversity of equipment types, local service requirements, facility sizes, and the continuing importance of hospital-employed teams and specialized regional providers.
Siemens Healthineers held an 8.2% share in 2025.
The company's position is reinforced by its installed base in diagnostic imaging and radiation therapy, where proprietary knowledge, specialized field service, and lifecycle coverage are central to customer retention. Its ability to integrate preventive and predictive maintenance into long-term managed service relationships strengthens its competitive position in high-complexity categories.
GE HealthCare held a 7.5% share in 2025.
GE HealthCare competes through multi-modality service coverage across imaging, monitoring, and life-care assets. Enterprise service agreements can combine maintenance with installation, training, and lifecycle upgrades, embedding the company more deeply in institutional capital-planning cycles.
Philips Healthcare held a 5.9% share in 2025.
Philips Healthcare's connected-care positioning supports integrated service relationships across imaging, monitoring, and clinical informatics. The approach is relevant for health systems seeking fewer maintenance vendors and more coordinated management of connected clinical assets.
Competition is most intense where ISOs can offer credible multi-vendor coverage, rapid local response, and cost advantages without compromising documentation or access to qualified parts. OEMs retain leverage in technically complex platforms, but independent providers can preserve attractive niches in specific modalities, geographies, and facility classes.
Recent Industry Developments
GE HealthCare — Sutter Health Care Alliance (January 2025): GE HealthCare and Sutter Health announced a seven-year strategic partnership that includes comprehensive maintenance and repair support for Sutter's imaging fleet across more than 300 ambulatory and hospital sites [6]GE HealthCare / Sutter Health (via BusinessWire). “Sutter Health and GE HealthCare enter strategic partnership.” businesswire.com. The arrangement illustrates how enterprise health systems are consolidating lifecycle management, preventive scheduling, upgrades, and service delivery under long-term vendor relationships.
Need a specific section of this report?
Purchase regional analysis, country-level analysis, company profiles, or any other segment-level insights separately
based on your research needs.
Frequently Asked Questions (FAQs):
Research methodology, data sources & validation process
This report draws on a structured research process built around direct industry conversations, proprietary modelling, and rigorous cross-validation and not just desk research.
Our 6-step research process
1. Research design & analyst oversight
At GMI, our research methodology is built on a foundation of human expertise, rigorous validation, and complete transparency. Every insight, trend analysis, and forecast in our reports is developed by experienced analysts who understand the nuances of your market.
Our approach integrates extensive primary research through direct engagement with industry participants and experts, complemented by comprehensive secondary research from verified global sources. We apply quantified impact analysis to deliver dependable forecasts, while maintaining complete traceability from original data sources to final insights.
2. Primary research
Primary research forms the backbone of our methodology, contributing nearly 80% to overall insights. It involves direct engagement with industry participants to ensure accuracy and depth in analysis. Our structured interview program covers regional and global markets, with inputs from C-suite executives, directors, and subject matter experts. These interactions provide strategic, operational, and technical perspectives, enabling well-rounded insights and reliable market forecasts.
3. Data mining & market analysis
Data mining is a key part of our research process, contributing nearly 20% to the overall methodology. It involves analysing market structure, identifying industry trends, and assessing macroeconomic factors through revenue share analysis of major players. Relevant data is collected from both paid and unpaid sources to build a reliable database. This information is then integrated to support primary research and market sizing, with validation from key stakeholders such as distributors, manufacturers, and associations.
4. Market sizing
Our market sizing is built on a bottom-up approach, starting with company revenue data gathered directly through primary interviews, alongside production volume figures from manufacturers and installation or deployment statistics. These inputs are then pieced together across regional markets to arrive at a global estimate that stays grounded in actual industry activity.
5. Forecast model & key assumptions
Every forecast includes explicit documentation of:
✓ Key growth drivers and their assumed impact
✓ Restraining factors and mitigation scenarios
✓ Regulatory assumptions and policy change risk
✓ Technology adoption curve parameter
✓ Macroeconomic assumptions (GDP growth, inflation, currency)
✓ Competitive dynamics and market entry/exit expectations
6. Validation & quality assurance
The final stages involve human validation, where domain experts manually review filtered data to identify nuances and contextual errors that automated systems might miss. This expert review adds a critical layer of quality assurance, ensuring data aligns with research objectives and domain-specific standards.
Our triple-layer validation process ensures maximum data reliability:
✓ Statistical Validation
✓ Expert Validation
✓ Market Reality Check
Trust & credibility
Verified data sources
Trade publications
Industry journals, trade publications, and specialized media.
Industry databases
Proprietary and third-party market databases
Regulatory filings
Government procurement records and policy documents
Academic research
University studies and specialist institution reports
Company reports
Annual reports, investor presentations, and filings
Expert interviews
C-suite, procurement leads, and technical specialists
GMI archive
13,000+ published studies across 20+ industry verticals
Trade data
Import/export volumes, HS codes, and customs records
Parameters studied & evaluated
Every data point in this report is validated through primary interviews, true bottom-up modelling, and rigorous cross-checks. Read about our research process →